000 01466 a2200421 4500
005 20250514191648.0
264 0 _c20040806
008 200408s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/sj.bjc.6601895
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKelly, J D
245 0 0 _aDownregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas.
_h[electronic resource]
260 _bBritish journal of cancer
_cJul 2004
300 _a164-70 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCarcinoma, Renal Cell
_xmetabolism
650 0 4 _aDown-Regulation
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xpharmacology
650 0 4 _aKidney Neoplasms
_xmetabolism
650 0 4 _aOligonucleotides, Antisense
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xbiosynthesis
650 0 4 _aThionucleotides
_xpharmacology
650 0 4 _aTumor Cells, Cultured
650 0 4 _afas Receptor
_xpharmacology
700 1 _aDai, J
700 1 _aEschwege, P
700 1 _aGoldberg, J S
700 1 _aDuggan, B P
700 1 _aWilliamson, K E
700 1 _aBander, N H
700 1 _aNanus, D M
773 0 _tBritish journal of cancer
_gvol. 91
_gno. 1
_gp. 164-70
856 4 0 _uhttps://doi.org/10.1038/sj.bjc.6601895
_zAvailable from publisher's website
999 _c14894938
_d14894938